Author(s):
Nirosha V., Gayathri V.
Email(s):
niroshanbalagan@gmail.com
DOI:
10.52711/2349-2996.2023.00048 
Address:
Nirosha V.1, Gayathri V.2
1Associate Professor, Vivekanandha College of Nursing, Tiruchengode, Namakkal.
2Nursing Tutor, Vivekanandha College of Nursing, Tiruchengode, Namakkal.
*Corresponding Author
Published In:
Volume - 13,
Issue - 3,
Year - 2023
ABSTRACT:
Depression is more than feeling a little sad or "blue" for a few days. Antidepressant medications are used in the treatment of clinical depression, usually alongside other forms of therapy such as psychological or behavioral therapy. Spravato is a medicine used to treat adults with major depression that is resistant to treatment. (Bahr, 2019) It is used in combination with an SSRI or SNRI medicine (other antidepressants) when at least two other treatments have failed. Spravato contains the active substance esketamine.
Cite this article:
Nirosha V., Gayathri V. Spravato (Esketamine). Asian Journal of Nursing Education and Research. 2023; 13(3):226-7. doi: 10.52711/2349-2996.2023.00048
Cite(Electronic):
Nirosha V., Gayathri V. Spravato (Esketamine). Asian Journal of Nursing Education and Research. 2023; 13(3):226-7. doi: 10.52711/2349-2996.2023.00048 Available on: https://ajner.com/AbstractView.aspx?PID=2023-13-3-12
REFERENCES:
1. https://www.spravato.com/
2. https://reference.medscape.com/drug/spravato-esketamine-intranasal-1000325
3. https://www.empr.com/drug/spravato/
4. https://www.centerwatch.com/drug-information/fda-approved-drugs/drug/100357/spravato-esketamine-nasal-spray
5. https://www.pharmaceutical-technology.com/news/fda-janssen-depression-drug-spravato/